Large outbreaks of pertussis occur despite vaccination. A first step in the analyses of outbreaks is strain typing. However, the typing of Bordetella pertussis, the causative agent of pertussis, is problematic because the available assays are insufficiently discriminatory, not unequivocal, time-consuming, and/or costly. Here, we describe a single nucleotide primer extension assay for the study of B. pertussis populations, SNPeX (single nucleotide primer extension), which addresses these problems. The assay is based on the incorporation of fluorescently labeled dideoxynucleotides (ddNTPs) at the 3= end of allele-specific poly(A)-tailed primers and subsequent analysis with a capillary DNA analyzer. Each single nucleotide polymorphism (SNP) primer has a specific length, and as a result, up to 20 SNPs can be determined in one SNPeX reaction. Importantly, PCR amplification of target DNA is not required. We selected 38 SNPeX targets from the whole-genome sequencing data of 74 B. pertussis strains collected from across the world. The SNPeX-based phylogenetic trees preserved the general tree topology of B. pertussis populations based on whole-genome sequencing, with a minor loss of details. We envisage a strategy whereby SNP types (SnpTs) are quickly identified with the SNPeX assay during an outbreak, followed by whole-genome sequencing (WGS) of a limited number of isolates representing predominant SnpTs and the incorporation of novel SNPs in the SNPeX assay. The flexibility of the SNPeX assay allows the method to evolve along with the pathogen, making it a promising method for studying outbreaks of B. pertussis and other pathogens.
L arge outbreaks of pertussis or whooping cough continue to occur, despite vaccination. One of the first steps to resolve the causes of infectious disease outbreaks is strain typing. Strain typing allows for placement of the outbreak in a larger geographical and temporal context, which is required to answer questions related to the origin, evolution, transmission, and characteristics of the outbreak strains. Strain typing can identify successful lineages from which isolates can be selected for more in-depth analysis. For example, whole-genome sequencing (WGS) can be used to reveal genetic loci that may have contributed to the fitness of the successful lineages. Thus, such epidemiologic studies depend on the availability of reproducible typing methods that discriminate between isolates at a desirable level (1, 2) . The typing of Bordetella pertussis, the causative agent of pertussis, is problematic due to its monomorphic character (3) (4) (5) (6) (7) . The currently used typing methods for B. pertussis include pulsed-field gel electrophoresis (PFGE), multilocus variable-number tandem-repeat analysis (MLVA), multiantigen sequence typing (MAST), and WGS (5, (8) (9) (10) (11) . WGS is the gold standard but is too expensive for use in routine surveillance. Further, the extraction of relevant data from sequenced genomes requires relatively complex software and expert knowledge. PFGE is currently the most broadly used method to characterize B. pertussis. It is highly discriminative but laborious and difficult to standardize (12) . Furthermore, it does not always reflect true genetic relationships, because variation may be introduced by recombination between insertion sequence elements, a process that can be reversed with relatively high frequency (6) . MLVA, which is PCR based and highly reproducible, is also broadly used, which allows comparisons of strains between different laboratories. However, MLVA is based on variations of only six loci, limiting its discriminatory power (6, 13) . For instance, several studies have shown that in the last 20 years, 46 to 74% of the strains belong to two MLVA types (MT), MT-27 and MT-29 (6, 12, 13) . Further, two major B. pertussis lineages characterized by different alleles for the pertussis toxin promoter, ptxP1 and ptxP3, are not always separated by MLVA (6, 12) . Finally, like PFGE, MLVA typing does not always reflect true genetic relationships, as polymorphisms are generated by a reversible variation in the number of tandem repeats (6) . MAST targets the alleles of five genes encoding B. pertussis proteins used in acellular vaccines (ACVs) (10, 14) , which limits its discriminatory power (12) . The advantage of MAST, however, is that it gives unequivocal results and allows the identification of vaccine escape strains (7, (14) (15) (16) (17) . The discriminatory power of MLVA and MAST can be increased by combining the two techniques (11, 12) .
The ideal typing method for molecular epidemiologic studies should be unequivocal, simple to use, have a high discriminatory power, and allow high-throughput analysis. For B. pertussis, it is also considered valuable to monitor the changes in the alleles of the components of acellular vaccines. Here, we describe a single nucleotide primer extension assay called SNPeX (single nucleotide primer extension), which complies with these criteria (i.e., is highly discriminatory, gives unequivocal results, is simple, and allows for high-throughput analyses). The assay is based on the incorporation of fluorescently labeled dideoxynucleotides (ddNTPs) into the 3= end of an allele-specific extension primer with a distinct length. Fragment analysis of the extension products is performed with a capillary DNA analyzer used in many laboratories. In this study, we present a SNPeX target set of 38 predefined single nucleotide polymorphisms (SNPs) that were selected from the WGS data of 74 worldwide strains. Importantly, the SNPeX targets were incorporated into two multiplex SNPeX assays, which were optimized for genomic DNA, without a PCR step. The flexibility of the SNPeX assay allows the method to evolve along with the pathogen, making it a promising method for studying outbreaks of B. pertussis and other pathogens.
MATERIALS AND METHODS
SNP selection. Shifts in MLVA types and in the virulence-associated alleles ptxP, ptxA, prn, and fim3 have been widely used to study the population dynamics of B. pertussis (reviewed in references 3 and 18). Therefore, the SNPs for the SNPeX assay were identified by the comparison of 74 genomes, the strains of which represent a diverse collection based on these polymorphic alleles. The strains were isolated between 1949 and 2010 in Africa, Europe, North America, and South America (5) . Based on these SNPs, a maximum parsimony tree was constructed using the Mix program from the PHYLIP package (19) (see Fig. S1 in the supplemental material). Supplemented with the tree, the program generated a table that lists the node divisions, along with the accountable SNP or multiple SNPs (see Table S1 in the supplemental material). From this list, the SNP targets for the SNPeX assay were selected. The selection criteria included nonconvergence, the occurrence of an SNP in at least two strains, and a minimum distance of 50 bp between the preceding and following SNP position. In addition, the region containing the SNP position was chosen to be part of the core genome, as described previously (20) . If multiple SNPs were available for a particular node division, a position was chosen at random. Further, at least one SNP was selected that is specific for the ptxP, ptxA, ptxC, and fim3 alleles, because these alleles have been included in many previous studies (see Table S2 in the supplemental material).
B. pertussis isolates and culture conditions. The bacteria were cultured for 3 to 4 days at 35°C on Bordet-Gengou (BG) agar plates that were supplemented with 15% sheep blood. B. pertussis strain B1917 was used to test the stability of the SNPeX targets by subculturing it 53 times. The colonies that were transferred 1, 25, and 53 times were typed with SNPeX. Two strains, B. pertussis B1203 and B1690, were analyzed twice from independently grown colonies in order to test the reproducibility of the SNPeX assay.
Two sets of isolates were analyzed using the SNPeX assay. The first set, collected from 1949 to 2010, contained 123 Dutch isolates that represented 83 MLVA types and 11 ptxP-ptxA-fim3 allele types (Table 1 ). In addition, 35 randomly selected Dutch isolates from 2008 to 2012 were added to this set. These included 11 isolates that were isolated early (Jan- Table S3 in the supplemental material). The second and more geographically diverse set comprised 60 strains from six continents and 16 countries (see Table S3 ). DNA isolation. Genomic DNA was isolated from B. pertussis isolates using the GenElute bacterial genomic DNA kit (Sigma-Aldrich, Zwijndrecht, the Netherlands), according to the manufacturer's instructions for Gram-negative bacteria. The minimum concentration of DNA required for the SNPeX assay was 200 ng/l. If possible, in order to achieve a minimum DNA concentration of 200 ng/l, the extraction buffer was evaporated by heating open reaction tubes at 40°C for 30 min to 2 h.
Multiantigen sequence typing. For MAST, the alleles for the pertussis toxin promoter (ptxP), regions 1 and 2 of the pertactin gene (prn), and the genes for serotype 2 fimbriae (fim2) and serotype 3 fimbriae (fim3) were sequenced as described previously (10, 21) .
Multilocus variable-number tandem-repeat analysis. The number of tandem repeats in six loci (VNTR1, VNTR3A, VNTR3B, VNTR4, VNTR5, and VNTR6) was determined as described before (11) .
SNPeX preview assay. Allele-specific primers were designed on the B. pertussis Tohama I genome sequence (National Center for Biotechnology Information [NCBI] reference sequence accession no. NC_002929) using the CLC Main Workbench 7.0.3 software (CLC bio, Aarhus, Denmark). The primers were purified by polyacrylamide gel electrophoresis (Eurogentec, Maastricht, the Netherlands). To assess the mobility of the four possible fluorescently labeled extension products of each primer, the products were visualized with a single-plex SNPeX preview assay using the SNaPshot primer focus kit (Life Technologies Corporation, CA, USA). The SNPeX preview assay was used to adjust the mix of primers to a suitable combination to prevent overlapping peaks (see Results). A SNPeX preview reaction mixture contained 0.1 l of primer focus enzyme, 4 l of primer focus ddNTP mix, 1 l of 10ϫ primer focus reaction buffer, 1 l of SNaPshot primer focus cofactor (Life Technologies Corporation), 1 l of primer (2 pmol/l), and 2.9 l of water. The reaction mixture was heated to 37°C for 15 min, followed by 70°C for 10 min. In order to remove unincorporated ddNTPs, 1 l of shrimp alkaline phosphatase (SAP) was added to the reaction mixture and incubated for 60 min at 37°C and 15 min at 72°C. Subsequently, 2 l of reaction product was dissolved in 10 l of GeneScan 120 LIZ size standard (100ϫ diluted) (Life Technologies Corporation) and denatured at 95°C for 5 min. After denaturation, the samples were run on a 48-capillary ABI Prism 3730 DNA analyzer (Applied Biosystems, CA, USA), using the POP-7 polymer and GeneMapper50_POP7_1 module.
SNPeX assay. The primers were dissolved into two reaction mixtures to a concentration of 0.5 to 4 pmol/l per primer. The concentration of the primer was adjusted to reach a fluorescence signal of 2,000 to 4,000 relative fluorescence units (RFUs) in the assay ( Table 2 ). The multiplex SNPeX assay was adjusted from that of Vallone et al. (22) , using the ABI Prism SNaPshot multiplex kit (Life Technologies Corporation, CA, USA) according to the manufacturer's instructions, with slight modifications. Briefly, 4 l of genomic DNA (Ͼ200 ng/l) was added to 1 l of primer mix. This mixture was denatured in a preheated thermal cycler at 95°C for 2 min, after which it was promptly put on ice and spun down. Five microliters of cold SNaPshot reaction mix (Life Technologies Corporation) was added to the sample, and the primer extension reaction was started, with denaturation at 95°C for 2 min, followed by 100 cycles of 96°C for 10 s and 61°C for 30 s. Unincorporated fluorescently labeled ddNTPs were removed by adding 1.5 l (1 U/l) of SAP to the mixture, followed by incubation for 60 min at 37°C. Afterwards, the enzyme was inactivated by incubation for 15 min at 80°C. Subsequently, 2 l of purified SNaPshot reaction product was added to 10 l of LIZ 120 size standard (100ϫ diluted) (Applied Biosystems, CA, USA). The samples were denatured for 5 min at 95°C, cooled down to room temperature, and run on a 48capillary ABI Prism 3730 DNA analyzer (Applied Biosystems). The GeneMapper50_POP7_1 run module was adjusted to a prerun time of 120 s, an injection volume of 5.0 kV, injection time of 20 s, data delay of 400 s, and run time of 650 s. Nucleotide incorporation was analyzed using GeneMarker 1.5.1 (Softgenetics, PA, USA).
Data analysis. Peak calling was performed using the software GeneMarker 1.5.1 (Softgenetics, State College, PA, USA), and the profiles were imported into BioNumerics 7.1 (Applied Maths, Sint-Martens-Latem, Belgium) as the character data and minimum spanning trees (MSTs) with hypothetical nodes were created. Each SNP position was treated as an independent categorical character. The tree was rooted with strains carrying the ptxP4 allele, as previous work showed that ptxP4 strains are most closely related to Bordetella bronchiseptica, a species from which B. pertussis has evolved (5, 23) . Ridom EpiCompare version 1.0.6 was used to calculate the discriminatory index (DI) and confidence interval (CI) of the SNPeX assay (Ridom Bioinformatics, Münster, Germany).
RESULTS

Selection of SNPeX targets from whole-genome sequences.
A comparison of 74 worldwide genomes revealed a total of 2,811 SNPs that were present in all strains (5) (see Table S4 in the supplemental material). An analysis of the maximum parsimony tree constructed with these SNPs, along with our selection criteria, resulted in 38 SNP targets ( Table 2) .
In silico evaluation of SNPeX targets. The 38 SNPeX targets were extracted in silico from the 74 genomes described above. The tree based on 2,811 SNPs derived from whole-genome sequences ( Fig. 1A ) was compared to the tree based on the selected 38 SNPeX targets ( Fig. 1B ; see also Fig. S2 in the supplemental material). With two exceptions (strains B3197 and B0585), the tree based on 2,811 SNPs distinguished all strains, resulting in 73 SNP types. The clustering of the same strains based on the 38 SNPs targeted by the SNPeX resulted in 34 SNPeX types (SnpTs). As expected, a reduction in the amount of SNPs used for clustering resulted in the coalescence of the branches. Importantly, the general topology (main branches) of the tree based on 2,811 SNPs was conserved. This was demonstrated by the conservation of the relative positions of most SnpTs in the SNPeX tree compared with the tree based on 2,811 SNPs (Fig. 1A) . However, not all relationships between the strains were preserved. For example, in the tree that resulted from the 2,811 SNPs, SnpT30 was centered between SnpT26, SnpT28, SnpT29, SnpT32, and SnpT33, but in the tree based on the selected 38 SNPeX targets, SnpT30 was directly connected to SnpT31 and SnpT29 only. The discriminatory indices of the complete whole-genome sequence SNP set and the SNPeX set were 1.00 (95% CI, 0.999 to 1.0) and 0.974 (95% CI, 0.965 to 0.983), respectively. Therefore, further SnpT designations were based on this SNPeX set.
Setup and principle of the method. Figure S3 in the supplemental material shows the principle of the SNPeX assay. Primers were designed that bind adjacent to each SNP position (see Table  S5 in the supplemental material). Each primer had a distinctive length (35 to 100 bp) due to a variable poly(A) tail. SNP typing was performed directly on DNA without an amplification step. For SNP identification, the primer was elongated at the targeted SNP with a fluorescently marked ddNTP, using fluorescent dyes specific for the four nucleotides. With this approach, the length of the elongation product defined the SNP position, whereas the color of the fluorescent nucleotide indicated the base at the SNP position. The sizing and determination of the color of a fragment is referred to as peak calling. Further, the variable length due to the poly(A) tail allowed for multiplexing.
Before the SNPeX assay could be applied to B. pertussis isolates, the suitability of each of the selected primers for multiplexing was assessed using a SNPeX preview reaction. Figure S4 in the supplemental material shows the principle of the SNPeX preview assay, using images of three primers used in this study. The primer focus enzyme in the SNPeX preview assay extends the primer with all four labeled nucleotides in a single-plex reaction. Note that there is no B. pertussis (or any other) DNA template present in this reaction. Subsequently, all potential extension products can be identified by capillary electrophoresis, and therefore, it can be verified that the products of different primers do not overlap in mobility. We designed the multiplex to have 19 and 20 primers in each mix. One primer appeared problematic in the SNP preview analysis because of overlapping peaks with other primers. We removed it from the first multiplex mix. The two mixes were incorporated into the SNPeX assay, which was performed directly on DNA without a PCR amplification step. The reactions were carried out in microtiter plates, allowing the analysis of 47 samples per plate (always including one reaction without template DNA as negative control). The costs of the SNPeX assay were approximately $6.00 per sample. An example of the multiplex SNPeX results of three strains and three primers is presented in Fig. S5 in the supplemental material. Turnaround time and success rate. Turnaround time is an important feature for a typing assay, especially when it concerns urgent pathogen typing during an epidemic. In this experimental design, a single person should be able to prepare 30 B. pertussis DNA samples per day from cells grown on agar plates. To carry out the SNPeX reaction, purify the fragments, and run the fragments takes 70, 75, and 30 min, respectively, per 96-well plate. Thus, after DNA isolation, it is possible to prepare and run two 96-well plates (equivalent to 95 strains and 38 SNPs) within 5 h. Table 2 ), and the length of the lines is scaled to the number of SNPs. The whole-genome sequences of these were published previously (5) . SnpT, SNPeX sequence type.
The in silico analyses required 3 h per run and included verification of the assignment of a nucleotide to an allele (peak calling, see Fig. S4 in the supplemental material) and preparation of an output file that lists the SNPs and allows secondary analyses (e.g., clustering). We were able to process four multiplex plates, equivalent to 192 strains, per working day (not including DNA isolation).
In total, the SNPeX reaction was performed on 260 samples, of which 200 samples directly revealed a complete SNP set (76% success rate). Most samples with an incomplete SNP set had a DNA concentration of Ͻ200 ng/l. One extra run was performed on the samples that had an incomplete set of SNPs, which resulted in 226 samples with a complete SNP set (86% success rate). A low DNA concentration was the main reason for the incomplete SNP sets.
Reproducibility and reliability. Throughout the 1ϫ, 25ϫ, and 53ϫ subculturing of a strain (B1917), all SNPs were identical (results not shown). Also, two strains were analyzed twice from independently grown colonies. The SNPs of both samples from a single isolate were identical (results not shown). In addition, 23 of the strains that were subjected to this SNPeX assay were also analyzed with WGS from independent cultures. The SNPs identified by the SNPeX assay were checked with the whole-genome data, and no discrepancies were found (results not shown).
Application of the SNPeX assay to type locally and globally collected isolates. SNPeX typing of 158 Dutch strains (isolated from 1949 to 2012) revealed 30 SnpTs ( Fig. 2A ; see also Table S3 in the supplemental material), with a diversity index of 0.912 (95% CI, 0.89 to 0.934). The isolates from the 2012 Dutch epidemic (n ϭ 11) belonged to SnpT12 (n ϭ 1), SnpT13 (n ϭ 1), SnpT31 (n ϭ 1), and SnpT32 (n ϭ 8). SnpT32 predominated during the 2012 epidemic but also in previous years since 2009 (Fig. 3) , which suggests that either the 2012 epidemic was not associated with the expansion of novel strains, or the SNPeX assay did not contain the SNPs that are characteristic of the 2012 strains. Preliminary WGS data showed that the strains from 2012 were characterized by two SNPs (reference positions in the Tohama I genome, 2570058 and 2570056), both located in a pseudogene (BP2427) (results not shown). The usefulness of the SNPeX assay was also explored using a more geographically diverse collection of B. pertussis strains (Fig. 2B) . SNPeX typing clustered the strains into 19 SnpTs, with a diversity index of 0.893 (95% CI, 0.85 to 0.94). As observed previously (5) , there was no evidence of geographic clustering.
The trees of the local (Dutch) and global strains ( Fig. 2A and B 1   ptxP1, ptxA2, fim3.1  ptxP1, ptxA2, fim3.1   ptxP1, ptxA1, fim3.1   ptxP1, ptxA1, fim3.1   ptxP3, ptxA1, fim3.2   ptxP3, ptxA1, fim3.2   ptxP3, ptxA1, fim3.1 ptxP3, ptxA1, fim3.1 isolates carrying the ptxP1/ptxP3 and fim3.1/fim3.2 alleles. Further, consistent with previous work (4, 5, 16, 24) , both trees revealed that the mutations in the ptxA, ptxP, and fim3 genes accumulated clonally. Progressing up the tree from the root, the ptxP allele generally changed from ptxP4 to ptxP1 to ptxP3, and the ptxA allele changed from ptxA5 to ptxA2 to ptxA1. In both trees, the ptxP3 clade was divided into two main branches that coincided with the fim3.1 and fim3.2 alleles. Branches characterized by distinct ptxP, ptxA, and fim3 alleles in the phylogenetic trees based on 2,811 SNPs from WGS analysis were retained in the tree based on the 38 SNPeX targets (see Fig. S2 in the supplemental material). To summarize, the trees based on only the 38 SNPs were very similar to previously published trees based on WGS (4, 5, 24) . Combining the SNPeX assay with MLVA. MLVA has been widely used to compare B. pertussis strains, although it does not accurately describe genetic relationships due to the reversibility of the number of repeats (6) . However, MLVA may be useful for subdividing the SnpTs. Therefore, the MLVA type of each Dutch strain carrying the ptxP3 allele (n ϭ 49) was determined, followed by hierarchical clustering (Fig. 4) . The strains were first clustered using the SNPeX assay, and subsequently, the SnpTs were subdivided based on MLVA type. This approach resulted in 17 combined SNPeX-MLVA types, of which the discriminatory index was 0.696 (95% CI, 0.55 to 0.84) (compared to a discriminatory indices of 0.58 [95% CI, 0.429 to 0.731] and 0.644 [95% CI, 0.49 to 0.797] based on SNPeX and MLVA only, respectively). The combined approach and the resulting tree revealed the convergence of MLVA types. For instance, MT27 was not only associated with the most prevalent SnpT32 but also with SnpT31 and SnpT33. This hierarchical approach establishes relationships between the strains by combining the relatively slow molecular clock based on SNPs together with the faster clock based on the insertion and deletion of repeats (MLVA) (25) . Although the combined approach does further subdivide the SnpTs, SnpT32-MT27 was predominant (n ϭ 27 [55%]). Also, 8 of 9 isolates from the 2012 epidemic were SnpT32-MT27, so MLVA did not further resolve the typing of these strains.
DISCUSSION
B. pertussis is a highly monomorphic pathogen, and current methods that are used to study B. pertussis populations either have low discriminatory power, are difficult to standardize, or do not reveal true genetic relationships due to convergence (6) . The ultimate approach to determine the relationships between strains is WGS. However, WGS is still relatively expensive, and the data analysis requires complex software. Here, we present the SNPeX assay, a fast, low-cost, and high-throughput method that types strains based on SNPs. Importantly, the SNPeX assay does not require the amplification of target DNA, greatly simplifying the method. Starting from purified DNA, it was possible to characterize 38 SNPs of 95 strains in 1 day. The assay requires the use of capillary electrophoresis platforms that are common in laboratories or can easily be employed by outsourcing. The method is based on the separation of primer extension products of distinct lengths, allowing for multiplexing up to 20 primers per microtiter plate well (see Fig. S3 in the supplemental material). In a previous study, we selected 87 SNPs for strain typing based on the Tohama I strain and six Dutch clinical isolates (6) . The selection of the 38 SNPeX positions targeted in this assay was based on the comparison of the genome sequences of 74 worldwide strains that yielded 2,811 SNPs; therefore, it is more useful for global studies. The two SNP sets overlap by 6 SNPs. The in silico comparison of the 38 SNP positions with the 2,811 SNPs derived from WGS revealed trees of very similar topology, despite the Ͼ70-fold reduction in the number of SNP positions addressed ( Fig. 1; see also Fig. S2 in the supplemental material). For example, both trees showed that the mutations in ptxA, ptxP, and fim3 genes accumulated clonally, and important branches were retained in the tree based on the smaller SNP set. The SNPeX assay was applied to a collection of temporally diverse Dutch isolates (isolated from 1949 to 2012) and a collection of geographically diverse worldwide isolates (from six continents and 16 countries, isolated between 1986 and 2010). In both cases, the trees showed the clonal accumulating changes in the ptxA, ptxP, and fim3 alleles. These allele patterns were also observed in the tree based on 2,811 SNPs from WGS (see Fig. S2 ) and have been considered to contribute to the persistence of pertussis (reviewed in references 3 and 18; see also reference 24). A limitation of this assay is that novel SNPs are not detected. SNPeX analyses of the strains isolated during the 2012 Dutch epidemic, in which SNPeX analysis did not reveal novel SnpTs compared to those of previous years, exemplifies this. The WGS analyses of these strains identified two unique SNPs associated with the 2012 strains, both which were present in a pseudogene (BP2427). In order to distinguish the 2012 strains, one of these could be selected and added to the SNPeX assay. Within the current primer length range, at least two primers could theoretically be added to each mix (e.g., with a total primer length of 38 or 56 bases in mix one, or total primer length of 40, 44, 64, or 76 bases in mix two). However, this scheme should be tested empirically. This exemplifies the SNPeX the strategy we envisage, i.e., the identification of predominant SnpTs during an outbreak, followed by WGS of a limited number of representatives of this SnpT. Subsequently, the SNPeX targets can be updated by WGS. SNPs may be added to, or removed from, the SNPeX assay as B. pertussis evolves. We have used a primer length range of 35 to 100 bases, but with the LIZ 120 marker that was used, it is theoretically possible to extend to a primer length of 120 bases, allowing the assay to incorporate another 20 primers (as differences in primer length should be at least two bases). Importantly, the data from the SNPeX assay can be compared to or complemented with the approximately 350 B.
pertussis whole-genome sequences available by in silico extraction of SNPs. Here, the assay was applied directly to DNA isolated from cultures. However, the inclusion of a PCR step that amplifies the region around each SNPeX target would allow the assay to be applied directly to clinical samples. This would require the development of multiplex PCR to limit the workload. The broad implementation of the SNPeX assay will reveal the global spread of successful lineages and enhance our understanding of how B. pertussis is able to cause large outbreaks even in highly vaccinated populations. MT22 -1993 MT22 - , 1990 MT5 SNP typing, and subsequently, MLVA types were assigned to the terminal branches. The ptxP, ptxA, and fim3 alleles are shown next to the branches. The alleles in bold type indicate their earliest appearance in the tree. The numbers on the connecting lines refer to the distance between the nodes. The circle size is relative to the number of strains with that particular combined SnpT/MT. Most ptxP3 strains (n ϭ 27 [55%]) belong to SnpT32-MT27. Note the occurrence of identical MTs in distinct SnpT branches (convergence, indicated by the extra ring around the SnpTs). Convergence suggests highly reversible mutations or strong selection. In both cases, such variable loci are less suitable for establishing relationships between strains. MT, MLVA type.
